IP Library › Granted Patent US 10,196,469
Granted Patent B2
US 10,196,469 · App. 14/914,460 · Granted Feb 5, 2019

Active energy ray curable resin composition, and cured product

Inventors: Satoshi Yamashita (Kyoto, JP); Sachiko Shimazu (Kyoto, JP); Kazunori Yoshida (Kyoto, JP)
Assignee: SANYO CHEMICAL INDUSTRIES, LTD.
C08F220/18C08F226/06C08F290/067C08F290/147C08G18/4825C08G18/672C08G18/755C08G18/7621C09D4/06C09D175/16C08F2220/1891
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,196,469
App. No.
14/914,460
Granted
Feb 5, 2019
Kind
B2
Abstract

The present invention provides an active energy ray-curable resin composition containing: (A) a monofunctional ethylenically unsaturated monomer free of urethane groups; (B) a polyfunctional ethylenically unsaturated monomer free of urethane groups; (C) a urethane group-containing ethylenically unsaturated monomer; (D) a photopolymerization initiator; (E) a polymerization inhibitor; and (F) a surfactant, wherein relative to the total weight of (A), (B), (C), (D), (E), and (F), the weight ratio of (A) is 45 to 90% by weight, the weight ratio of (B) is 3 to 25% by weight, the weight ratio of (C) is 3 to 35% by weight, the weight ratio of (D) is 0.1 to 10% by weight, the weight ratio of (E) is 0.01 to 5% by weight, and the weight ratio of (F) is 0.1 to 10% by weight, and the resin composition has a surface tension of 20 to 30 mN/m.

Claims (16)

1. An active energy ray-curable resin composition comprising:

(A) an alicyclic skeleton-containing (meth)acrylate selected from the group consisting of isobornyl (meth)acrylate, adamantyl (meth)acrylate, and dicyclopentanyl (meth)acrylate;

(B) an alicyclic skeleton-containing di(meth)acrylate selected from the group consisting of cyclohexane dimethanol di(meth)acrylate and dimethyloltricyclodecane di(meth)acrylate;

(C) a urethane group-containing ethylenically unsaturated monomer which is a reaction product of (a2) an ε-caprolactone adduct of an alkylene oxide adduct of (meth)acrylic acid and (b) an alicyclic polyisocyanate or a nurate compound thereof;

(D) a photopolymerization initiator selected from the group consisting of a phosphine oxide and an acetophenone compound;

(E) a polymerization inhibitor selected from the group consisting of a phenol compound and an amine compound; and

(F) a surfactant which is a polysiloxane modified with an amino group and a polyether group,

wherein relative to the total weight of (A), (B), (C), (D), (E), and (F), the weight ratio of (A) is 45 to 90% by weight, the weight ratio of (B) is 3 to 25% by weight, the weight ratio of (C) is 3 to 35% by weight, the weight ratio of (D) is 0.1 to 10% by weight, the weight ratio of (E) is 0.01 to 5% by weight, and the weight ratio of (F) is 0.1 to 10% by weight, and

the resin composition has a surface tension of 20 to 30 mN/m.

2. The active energy ray-curable resin composition according to claim 1 ,

wherein a cured product obtained by active energy ray irradiation has a glass transition temperature of 50° C. to 150° C.

3. A cured product obtained by curing the active energy ray-curable resin composition according to claim 1 by active energy ray irradiation.

4. The active energy ray-curable resin composition according to claim 1 , wherein the alicyclic skeleton-containing (meth)acrylate (A) is selected from the group consisting of isobornyl (meth)acrylate and adamantyl (meth)acrylate.

5. The active energy ray-curable resin composition according to claim 1 , wherein (C) is a reaction product of (a2) an ε-caprolactone adduct of an alkylene oxide adduct of (meth)acrylic acid and (b) isophorone diisocyanate (IPDI) or a nurate compound thereof.

6. The active energy ray-curable resin composition according to claim 1 , wherein the photopolymerization initiator (D) is selected from the group consisting of 1-hydroxycyclohexyl phenyl ketone, 2,4,6-trimethylbenzoyl diphenylphosphine oxide, and bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide.

7. The active energy ray-curable resin composition according to claim 1 , wherein the polymerization inhibitor (E) is selected from the group consisting of phenothiazine and hydroquinone monomethyl ether.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2016
From: YAMASHITA, SATOSHI; SHIMAZU, SACHIKO; YOSHIDA, KAZUNORI
To: SANYO CHEMICAL INDUSTRIES, LTD.
Reel/Frame 038185/0655 →
Priority Claims (1)
JP 2013-188514 · Sep 11, 2013 · national
Continuity (1)
Related Publication 20160222146A1 · Aug 4, 2016